AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Trastuzumab in South Africa
8 products registered with SAHPRA — 7 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| EQUTTUZ | 56/26/0441 | Equity Pharmaceutical (Pty) Ltd | active | 21 Jan 2030 |
| HERCLON | 46/26/0866 | Roche Products (Pty) Ltd | suspended | 1 Jul 2026 |
| Hertuzu 150 mg | 53/26/0601.598 | Adcock Ingram Limited | active | 1 Jan 1900 |
| HERCEPTIN 21 mg/ml IV | 34/26/0419 | Roche Products (Pty) Ltd | active | 1 Jan 1900 |
| Herzuma 440 mg | 53/26/0599 | Adcock Ingram Limited | active | 1 Jan 1900 |
| HERCEPTIN SC 600 mg | 48/26/1244 | Roche Products (Pty) Ltd | active | 1 Jan 1900 |
| Herzuma 150 mg | 53/26/0598 | Adcock Ingram Limited | active | 1 Jan 1900 |
| Hertuzu 440 mg | 53/26/0602.599 | Adcock Ingram Limited | active | 1 Jan 1900 |
Trastuzumab — SAHPRA Registration Details
SAHPRA (South Africa) has 8 registered products containing Trastuzumab, of which 7 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Trastuzumab registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.